CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma
Hoofdauteurs: | Guang Wang, Juan Fu, Mulin Liu, Qin Zheng |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Public Library of Science (PLoS)
2024-01-01
|
Reeks: | PLoS ONE |
Online toegang: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI |
Gelijkaardige items
-
CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
door: Guang Wang, et al.
Gepubliceerd in: (2024-01-01) -
Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
door: Jiacheng Huang, et al.
Gepubliceerd in: (2021-08-01) -
The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma
door: Yonghui Wang, et al.
Gepubliceerd in: (2020-01-01) -
The Role of CXC Chemokines in Cardiovascular Diseases
door: Xiyi Lu, et al.
Gepubliceerd in: (2022-05-01) -
Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
door: Tesfaye Wolde, et al.
Gepubliceerd in: (2024-02-01)